Ligand validation:6LXY

EXF: N-[(2R)-2-fluoranyl-3-methyl-3-oxidanyl-butyl]-6-[(6-fluoranylpyrazolo[1,5-a]pyrimidin-5-yl)amino]-4-(propan-2-ylamino)pyridine-3-carboxamide

EXF is a Ligand Of Interest in 6LXY designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LXY_EXF_D_502	76%	21%	0.127	0.964	1.92	1.41	8	3	0	0	100%	1
6LXY_EXF_E_502	72%	16%	0.126	0.95	2.12	1.59	8	2	0	0	100%	1
6LXY_EXF_B_502	71%	17%	0.137	0.959	1.96	1.66	9	4	0	0	100%	1
6LXY_EXF_A_501	68%	16%	0.144	0.956	2.1	1.59	8	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.